Merck Tbk (MERK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Merck Tbk (MERK) has a cash flow conversion efficiency ratio of 0.166x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp137.63 Billion ≈ $8.06 Million USD) by net assets (Rp829.78 Billion ≈ $48.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Merck Tbk for the company's overall valuation and market capitalisation.
Merck Tbk - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how Merck Tbk's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Merck Tbk Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Merck Tbk ranked by their cash flow conversion efficiency. Explore Merck Tbk cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Deleum Bhd
KLSE:5132
|
0.116x |
|
Mobile Infrastructure Corporation
NASDAQ:BEEP
|
-0.010x |
|
Evergreen Max Cash Capital Berhad
KLSE:0286
|
-0.215x |
|
Sound Financial Bancorp Inc
NASDAQ:SFBC
|
0.018x |
|
Golden Bridge Electech Inc
TW:6133
|
0.023x |
|
SkyWorld Development Berhad
KLSE:5315
|
-0.182x |
|
Balyo SA
PA:BALYO
|
-1.908x |
|
BMT Co. Ltd
KQ:086670
|
-0.050x |
Annual Cash Flow Conversion Efficiency for Merck Tbk (2000–2024)
The table below shows the annual cash flow conversion efficiency of Merck Tbk from 2000 to 2024. View Merck Tbk (MERK) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp807.27 Billion ≈ $47.30 Million |
Rp55.71 Billion ≈ $3.26 Million |
0.069x | -73.06% |
| 2023-12-31 | Rp795.88 Billion ≈ $46.64 Million |
Rp203.87 Billion ≈ $11.95 Million |
0.256x | +75.83% |
| 2022-12-31 | Rp757.24 Billion ≈ $44.37 Million |
Rp110.32 Billion ≈ $6.46 Million |
0.146x | -41.31% |
| 2021-12-31 | Rp684.04 Billion ≈ $40.08 Million |
Rp169.81 Billion ≈ $9.95 Million |
0.248x | +111.30% |
| 2020-12-31 | Rp612.68 Billion ≈ $35.90 Million |
Rp71.98 Billion ≈ $4.22 Million |
0.117x | +133.10% |
| 2019-12-31 | Rp594.01 Billion ≈ $34.81 Million |
Rp-210.84 Billion ≈ $-12.35 Million |
-0.355x | -208.88% |
| 2018-12-31 | Rp518.28 Billion ≈ $30.37 Million |
Rp168.96 Billion ≈ $9.90 Million |
0.326x | +54.43% |
| 2017-12-31 | Rp615.44 Billion ≈ $36.06 Million |
Rp129.92 Billion ≈ $7.61 Million |
0.211x | +180.84% |
| 2016-12-31 | Rp582.67 Billion ≈ $34.14 Million |
Rp43.80 Billion ≈ $2.57 Million |
0.075x | -77.85% |
| 2015-12-31 | Rp473.54 Billion ≈ $27.75 Million |
Rp160.70 Billion ≈ $9.42 Million |
0.339x | -19.30% |
| 2014-12-31 | Rp553.69 Billion ≈ $32.44 Million |
Rp232.83 Billion ≈ $13.64 Million |
0.420x | +61.82% |
| 2013-12-31 | Rp512.22 Billion ≈ $30.01 Million |
Rp133.10 Billion ≈ $7.80 Million |
0.260x | +22.49% |
| 2012-12-31 | Rp416.74 Billion ≈ $24.42 Million |
Rp88.40 Billion ≈ $5.18 Million |
0.212x | -32.90% |
| 2011-12-31 | Rp494.18 Billion ≈ $28.96 Million |
Rp156.23 Billion ≈ $9.15 Million |
0.316x | -28.09% |
| 2010-12-31 | Rp363.02 Billion ≈ $21.27 Million |
Rp159.58 Billion ≈ $9.35 Million |
0.440x | +91.60% |
| 2009-12-31 | Rp354.18 Billion ≈ $20.75 Million |
Rp81.26 Billion ≈ $4.76 Million |
0.229x | -27.60% |
| 2008-12-31 | Rp327.32 Billion ≈ $19.18 Million |
Rp103.73 Billion ≈ $6.08 Million |
0.317x | +28.61% |
| 2007-12-31 | Rp280.23 Billion ≈ $16.42 Million |
Rp69.05 Billion ≈ $4.05 Million |
0.246x | -36.50% |
| 2006-12-31 | Rp235.58 Billion ≈ $13.80 Million |
Rp91.42 Billion ≈ $5.36 Million |
0.388x | +79.51% |
| 2005-12-31 | Rp180.38 Billion ≈ $10.57 Million |
Rp38.99 Billion ≈ $2.28 Million |
0.216x | -39.90% |
| 2004-12-31 | Rp154.04 Billion ≈ $9.03 Million |
Rp55.40 Billion ≈ $3.25 Million |
0.360x | -11.02% |
| 2003-12-31 | Rp159.51 Billion ≈ $9.35 Million |
Rp64.48 Billion ≈ $3.78 Million |
0.404x | +113.28% |
| 2002-12-31 | Rp149.25 Billion ≈ $8.75 Million |
Rp28.29 Billion ≈ $1.66 Million |
0.190x | -38.74% |
| 2001-12-31 | Rp127.49 Billion ≈ $7.47 Million |
Rp39.44 Billion ≈ $2.31 Million |
0.309x | -24.27% |
| 2000-12-31 | Rp96.86 Billion ≈ $5.68 Million |
Rp39.57 Billion ≈ $2.32 Million |
0.409x | -- |
About Merck Tbk
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. The company operates through Biopharma, Consumer Health, and Others segments. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in research an… Read more